Oxford BioMedica PLC (OXBDF)
3.86
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Oxford BioMedica Total Liabilities (Quarterly): 222.31M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 222.31M |
| June 30, 2023 | 255.93M |
| June 30, 2023 | 255.93M |
| December 31, 2022 | 271.07M |
| June 30, 2022 | 250.69M |
| June 30, 2022 | 250.69M |
| December 31, 2021 | 67.33M |
| June 30, 2021 | 90.07M |
| June 30, 2021 | 90.07M |
| December 31, 2020 | 97.01M |
| June 30, 2020 | 63.21M |
| June 30, 2020 | 63.21M |
| December 31, 2019 | 62.02M |
| June 30, 2019 | 61.94M |
| June 30, 2019 | 61.94M |
| December 31, 2018 | 98.54M |
| June 30, 2018 | 91.01M |
| June 30, 2018 | 91.01M |
| December 31, 2017 | 80.08M |
| June 30, 2017 | 62.35M |
| June 30, 2017 | 62.35M |
| December 31, 2016 | 54.46M |
| June 30, 2016 | 60.15M |
| June 30, 2016 | 60.15M |
| December 31, 2015 | 60.68M |
| Date | Value |
|---|---|
| June 30, 2015 | 38.02M |
| June 30, 2015 | 38.02M |
| December 31, 2014 | 16.76M |
| June 30, 2014 | 9.546M |
| June 30, 2014 | 9.546M |
| December 31, 2013 | 7.826M |
| June 30, 2013 | 6.698M |
| June 30, 2013 | 6.698M |
| December 31, 2012 | 7.724M |
| June 30, 2012 | 12.82M |
| June 30, 2012 | 12.82M |
| December 31, 2011 | 12.83M |
| June 30, 2011 | 18.44M |
| December 31, 2010 | 21.67M |
| June 30, 2010 | 26.03M |
| December 31, 2009 | 37.15M |
| June 30, 2009 | 49.89M |
| December 31, 2008 | 29.08M |
| June 30, 2008 | 48.25M |
| December 31, 2007 | 58.05M |
| June 30, 2007 | 55.12M |
| December 31, 2006 | 10.67M |
| June 30, 2006 | 12.17M |
| December 31, 2005 | 4.542M |
| June 30, 2005 | 4.733M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
61.94M
Minimum
Jun 2019
271.07M
Maximum
Dec 2022
144.23M
Average
90.07M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 233.64M |
| Biodexa Pharmaceuticals Plc | 7.470M |
| Verona Pharma PLC | 64.92M |
| NuCana PLC | 16.46M |
| Autolus Therapeutics PLC | 263.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 321.46M |
| Shareholders Equity (Quarterly) | 94.28M |
| Debt to Equity Ratio | 0.5207 |
| Current Ratio | 3.189 |
| Net Debt Paydown Yield | 4.34% |